Hormone-modulating therapy may reduce dementia risk in breast cancer
Jul 25, 2024
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...